The Effect of Inhalation Agent on the QTc Interval During Liver Transplantation: Sub Study (NCT01886664)

• Status: Completed
• Trial end date: 2013-11-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the effects of inhalation agent on corrected QT interval duration during liver transplantation.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Seoul National University Hospital
• Treatments: Desflurane; Sevoflurane

Criteria

Inclusion Criteria:

• elective liver transplantation

Exclusion Criteria:

• age < 18, age > 65

• patient refusal

• re-transplantation